Nano-Stevia reduces the liver injury caused by streptozotocin (STZ)-induced diabetes in rats by targeting PEPCK/GCK genes, INSR pathway and apoptosis

Neda Mousavi-Niri,Fatemeh Khakpai,Marzieh Moheb-Alian,Elham Ghanimati,Faezeh Abdollah-Pour,Maryam Naseroleslami
DOI: https://doi.org/10.1007/s40200-023-01278-2
2023-08-30
Abstract:Extensive application of stevia in the treatment of type 2 diabetes mellitus (DM) has been proven by a large number of previous studies. We prepared stevia loaded in nanoniosomes (nanostevia) to improve its bioavailability, functionality, and stability and explore its protective effects and underlying mechanisms in the liver of STZ-induced diabetic rats.
What problem does this paper attempt to address?